KINCISE for Osteoarthritis, Hip

Phase-Based Progress Estimates
Osteoarthritis, Hip
KINCISE - Device
All Sexes
What conditions do you have?

Study Summary

This trial is looking at the effects of mental health and wellness on patients who have had hip replacement surgery, in terms of how well they recover physically and mentally.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: 1 year

1 year
The Patient Health Questionnaire20 (PHQ-9)
The Short Form (36) Health Survey

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

1 of 2
Traditional Mallet
1 of 2
Active Control
Non-Treatment Group

50 Total Participants · 2 Treatment Groups

Primary Treatment: KINCISE · Has Placebo Group · N/A

ActiveComparator Group · 1 Intervention: KINCISE · Intervention Types: Device
Traditional Mallet
PlaceboComparator Group · 1 Intervention: Traditional Handheld Mallet · Intervention Types: Device

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 1 year

Who is running the clinical trial?

University of CincinnatiLead Sponsor
385 Previous Clinical Trials
630,448 Total Patients Enrolled
Todd A Kelley, MDPrincipal InvestigatorUniversity of Cincinnati

Eligibility Criteria

Age 18+ · All Participants · 2 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are eligible to participate if you are a male or female over age 21 with a compatible smartphone (Apple iPhone 6s or newer running iOS 13 or higher).

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 22nd, 2021

Last Reviewed: October 27th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.